Skip to content

Arrhythmias in Patients With COVID-19

The ACOVID-19 Study - A Prospective Cohort Study Investigating the Acute Effect of COVID-19 on the Heart by Continuous ECG Monitoring

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04395664
Acronym
ACOVID
Enrollment
1000
Registered
2020-05-20
Start date
2020-04-16
Completion date
2020-09-01
Last updated
2020-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Brief summary

The study is a prospective clinical cohort study of consecutive patients hospitalized at all hospitals of greater Copenhagen with a laboratory confirmed diagnosis of COVID-19. The investigators aim to examine if continuous ECG monitoring can be used to understand the contribution of COVID-19 infection in the acute phase to the development of cardiac arrhythmias, especially focusing on cardiovascular outcomes. In all patients included, the investigators aim to examine if continuous ECG monitoring - alone and in combination with biomarkers - can be used to detect early signs of cardiac complications and predict long-term risk of cardiovascular morbidity and mortality following COVID-19 infection.

Interventions

ECG monitoring

Sponsors

Herlev and Gentofte Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients hospitalized at hospitals of greater Copenhagen area and Zealand with a laboratory confirmed diagnosis of COVID-19 \> 18 years of age.

Exclusion criteria

* Persons not able to cooperate * Persons unable to understand and sign informed consent

Design outcomes

Primary

MeasureTime frame
In-hospital mortality during hospitalization and a confirmed COVID-19 diagnosis4 months
Incident intensive care unit admission during hospitalization and a confirmed COVID-19 diagnosis4 months

Secondary

MeasureTime frame
Incident pulmonary embolism during hospitalization and a confirmed COVID-19 diagnosis4 months
Incident cardiac arrest during hospitalization and a confirmed COVID-19 diagnosis4 months
Incident hypoxic respiratory failure during hospitalization and a confirmed COVID-19 diagnosis4 months

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026